Compounds > 3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole
Page last updated: 2024-09-03

3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole and memantine

3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole has been researched along with memantine in 1 studies

Compound Research Comparison

Studies
(3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole)		Trials
(3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole)		Recent Studies (post-2010)
(3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole)		Studies
(memantine)		Trials
(memantine)		Recent Studies (post-2010) (memantine)
682182,6843411,425

Protein Interaction Comparison

ProteinTaxonomy3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (IC50)memantine (IC50)
Neuronal acetylcholine receptor subunit alpha-3Rattus norvegicus (Norway rat)6
Neuronal acetylcholine receptor subunit beta-4Rattus norvegicus (Norway rat)6
AcetylcholinesteraseHomo sapiens (human)0.0049
Glutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)1.4167
Neuronal acetylcholine receptor subunit alpha-6Rattus norvegicus (Norway rat)6
Glutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)1.4167
Glutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)1.5
Glutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)1.5
Glutamate receptor ionotropic, NMDA 1Homo sapiens (human)4.3212
Glutamate receptor ionotropic, NMDA 2AHomo sapiens (human)3.662
Glutamate receptor ionotropic, NMDA 2BHomo sapiens (human)5.31
Glutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)1.5
Glutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)1.5
Glutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)1.5

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Franke, AG; Huss, M; Konrad, A; Lieb, K1

Reviews

1 review(s) available for 3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole and memantine

ArticleYear
[Stimulant and non-stimulant medication in current and future therapy for ADHD].
    Fortschritte der Neurologie-Psychiatrie, 2012, Volume: 80, Issue:3

    Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Central Nervous System Stimulants; Child; Dextroamphetamine; Fatty Acids, Omega-3; Guanfacine; Histamine Agonists; Humans; Isoxazoles; Lisdexamfetamine Dimesylate; Memantine; Methylphenidate; Modafinil; Off-Label Use; Propylamines; Pyridines; Pyrrolidines; Receptors, AMPA

2012